HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Philippe Pibarot Selected Research

Bioprosthesis

9/2015Patient and procedure selection for the prevention of prosthesis-patient mismatch following aortic valve replacement.
2/2014Lp-PLA2 is associated with structural valve degeneration of bioprostheses.
4/2013Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis.
5/2009Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis.
9/2006Value and limitations of peak-to-peak gradient for evaluation of aortic stenosis.
2/2003Discrepancies between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon: practical implications with regard to quantification of aortic stenosis severity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Philippe Pibarot Research Topics

Disease

37Aortic Valve Stenosis (Aortic Stenosis)
12/2015 - 02/2003
11Mitral Valve Insufficiency (Mitral Regurgitation)
09/2015 - 02/2007
10Pathologic Constriction (Stenosis)
11/2015 - 09/2002
8Inflammation
08/2015 - 01/2008
6Obesity
12/2014 - 09/2007
6Atrial Fibrillation
03/2014 - 09/2007
5Hypertension (High Blood Pressure)
12/2014 - 04/2010
4Heart Failure
05/2015 - 01/2009
4Atherosclerosis
01/2012 - 01/2006
3Abdominal Obesity
12/2015 - 06/2008
3Hypertrophy
09/2015 - 04/2010
3Coronary Artery Disease (Coronary Atherosclerosis)
02/2014 - 04/2008
3Pulmonary Hypertension (Ayerza Syndrome)
10/2013 - 03/2007
2Diabetes Mellitus
10/2014 - 04/2010
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
10/2014 - 02/2013
2Fibrosis (Cirrhosis)
09/2014 - 01/2014
2Aortic Valve Insufficiency (Aortic Regurgitation)
06/2013 - 04/2013
2Left Ventricular Dysfunction
01/2009 - 01/2008
1Death (Near-Death Experience)
09/2015
1Hemolysis
06/2015
1Necrosis
06/2015
1Cardiomyopathies (Cardiomyopathy)
01/2015
1Renal Insufficiency (Renal Failure)
12/2014
1Type 2 Diabetes Mellitus (MODY)
10/2014
1Dyslipidemias (Dyslipidemia)
10/2014
1Stroke (Strokes)
07/2014
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
10/2013
1Weight Loss (Weight Reduction)
08/2013
1Dyspnea (Shortness of Breath)
08/2013
1Insulin Resistance
02/2013
1Heart Diseases (Heart Disease)
01/2013
1Connective Tissue Diseases (Connective Tissue Disease)
01/2013
1Pneumonia (Pneumonitis)
11/2012
1Pain (Aches)
11/2012
1Amyloid Plaque
10/2012
1Amyloidosis
12/2011
1Hypercholesterolemia
04/2010
1Chronic Obstructive Pulmonary Disease (COPD)
04/2010

Drug/Important Bio-Agent (IBA)

8DobutamineFDA LinkGeneric
11/2015 - 02/2006
5Biological Markers (Surrogate Marker)IBA
06/2015 - 06/2008
5Brain Natriuretic Peptide (Natrecor)FDA Link
10/2014 - 06/2007
4rosuvastatin (Crestor)FDA Link
09/2015 - 04/2010
3CalciumIBA
11/2015 - 07/2010
3pro-brain natriuretic peptide (1-76)IBA
01/2015 - 08/2013
3SASIBA
12/2014 - 01/2007
3CholesterolIBA
10/2014 - 01/2009
3oxidized low density lipoproteinIBA
12/2010 - 01/2006
2Insulin (Novolin)FDA Link
12/2015 - 01/2009
2Lipoprotein(a)IBA
09/2015 - 08/2015
2LipidsIBA
02/2014 - 01/2006
2HDL CholesterolIBA
02/2014 - 01/2009
2Lipoproteins (Lipoprotein)IBA
02/2014 - 01/2009
2Angiotensin Receptor AntagonistsIBA
01/2014 - 12/2013
2Amyloid (Amyloid Fibrils)IBA
10/2012 - 12/2011
2CytokinesIBA
01/2012 - 01/2006
2ResistinIBA
01/2012 - 07/2010
2Metoprolol (Lopressor)FDA LinkGeneric
02/2010 - 06/2005
2Morphine (MS Contin)FDA LinkGeneric
10/2003 - 09/2002
1Carrier Proteins (Binding Protein)IBA
12/2015
1Apolipoproteins B (ApoB)IBA
09/2015
1PhospholipidsIBA
09/2015
11-penicillamyl-Leu(2)- oxytocinIBA
09/2015
1lysophosphatidic acid (MOPA)IBA
08/2015
1Hemoglobins (Hemoglobin)IBA
06/2015
1carbonic anhydrase XIIIBA
05/2015
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2015
1Insulin-Like Growth Factor II (Somatomedin A)IBA
10/2014
1Sucrose (Saccharose)IBA
10/2014
1Apolipoprotein B-100 (Apo B 100)IBA
10/2014
1matrix Gla proteinIBA
09/2014
1Scavenger Receptors (Scavenger Receptor)IBA
02/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2013
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
12/2013
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
06/2013
1Complement System Proteins (Complement)IBA
01/2013
1tranilast (N 5')IBA
01/2013
1TeaIBA
11/2012
1Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2012
1Warfarin (Coumadin)FDA LinkGeneric
08/2012
1CreatinineIBA
12/2011
1Angiotensin IIIBA
12/2010
1Toll-Like Receptor 2IBA
06/2010
1Phospholipid Transfer ProteinsIBA
06/2010
1BiglycanIBA
06/2010
1Proteins (Proteins, Gene)IBA
06/2010
1LDL CholesterolIBA
04/2010

Therapy/Procedure

14Prostheses and Implants (Prosthesis)
06/2015 - 01/2006
8Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2015 - 09/2007
6Bioprosthesis
09/2015 - 02/2003
4Catheters
04/2013 - 02/2003
4Mitral Valve Annuloplasty
11/2009 - 02/2007
2Decompression
05/2015 - 01/2015
2Analgesia
11/2012 - 09/2002
2Transplants (Transplant)
04/2008 - 09/2007
1Surgical Instruments (Clip)
09/2014
1Bariatric Surgery
08/2013
1Thoracotomy
11/2012
1Tracheostomy
11/2012
1Blood Transfusion (Blood Transfusions)
04/2010